RenovaCare Announces Termination of StemCell Systems R&D Agreement
SCOTTSDALE, Ariz., May 03, 2022 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), a clinical-stage developer of patented...
RenovaCare Announces Management Changes
SCOTTSDALE, Ariz., March 24, 2022 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), a clinical-stage developer of patented...
RenovaCare Provides Clinical and Corporate Update
SCOTTSDALE, Ariz., March 09, 2022 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), a clinical-stage developer of patented...
SHAREHOLDER ALERT: Robbins LLP Investigates RenovaCare, Inc. (RCAR) on Behalf of Investors
Shareholder rights law firm Robbins LLP is investigating RenovaCare, Inc. (OTC: RCAR) to determine whether RenovaCare officers and directors violated the Securities Exchange Act of 1934 and breached...